Drugs / YAM80
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00886977 | Apr 2009 → Dec 2010 | amyotrophic lateral sclerosis | Yoshino Neurology Clinic | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | YAM80 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00886977 ↗ |
| Route | Oral | “Oral administration, 2 to 6 mg, once a day.” NCT00886977 ↗ |